Swiss investment bank UBS Group made a strategic move on Friday by purchasing shares of 29 prominent companies, including Fortis Healthcare, Max Financial Services, and Reliance Industries, for a t
Prabhudas Lilladher has reaffirmed its Buy rating on Fortis Healthcare (FORH), setting a revised target price of Rs 710, indicating a potential upside from the current market price of Rs 621.
Fortis Healthcare Ltd has announced that its board has approved the issuance of non-convertible debentures (NCDs) worth Rs 1,500 crore via private placement.